medigraphic.com
SPANISH

MediSan

ISSN 1029-3019 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 09

<< Back Next >>

MediSan 2013; 17 (09)

Revascularization and Heberprot-P® in an elderly

Pichín QA, Díaz HD, Sancho SAN, Sánchez GD, Franco MMC
Full text How to cite this article

Language: Spanish
References: 10
Page: 5098-6003
PDF size: 150.59 Kb.


Key words:

elderly, peripheral arterial disease, revascularization, Heberprot-P®, secondary health care.

ABSTRACT

The case report of a 66 year-old patient is presented, who had intense pain in the right foot, after a trauma, and after observing a change of colour in the great toe of the same foot, reason why he was admitted for better study and treatment. Revascularization of the affected extremity was carried out and Heberprot-P® was used as therapeutic complement (12 applications). The pain disappeared totally and the index ankle - arm of the affected inferior member reached normal values. The aged patient was discharged after 10 days of revascularization and at the third week of applying the product a productive granulation tissue had been achieved. There were neither adverse reactions to the medication, nor local infection, so that the foot was completely functional.


REFERENCES

  1. Hirsch AT, Hiatt WR. PAD awareness, risk, and treatment: new resources for survival the USA Partners Program. Vasc Med. 2001; 6(3): 9-12.

  2. Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD. The correlation between symptoms and non – invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996; 1(1): 65-71.

  3. McDermott MM, Mehta S, Greeland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999; 159(4): 387-92.

  4. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the the women's health and aging study. Circulation. 2000; 101(9): 1007-12.

  5. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA. 2001; 286(13): 1599-1606.

  6. Nehler MR, Coll JR, Hiatt WR, Regensteiner JG, Schnickel GT, Klenke WA. Functional outcome in a contemporary series of major lower extremity amputations. J Vasc Surg. 2003; 38(1):7-14.

  7. Hooi Jd, S Toffers HE, Kester Ad. Peripheral arterial occlusive disease: Prognostic value of signs, symptoms, and the ankle- brachial pressure index. Med Decis Making. 2002; 22(2): 90- 107.

  8. Dos Santos JC. Sur la desobstruction des thrombus arterielles ancienes. Mem Acad Chir.1947; 73: 409.

  9. Nelson PR, Powell RJ, Proia RR. Results of endovascular superficial femoral endarterectomy. J Vasc Surg. 2001; 34(3):526-31.

  10. Rosenthal D, Wellons ED, Matsurra JH, Ghegan M, Shuler FW, Laszlo Pallos L. Remote superficial femoral artery endarterectomy and distal vein bypass for limb salvage: initial experience. J Endavasc Ther. 2003; 10(1):121.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MediSan. 2013;17